Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe recruitment status was updated to indicate that this study is no longer looking for participants. Other changes relate to page navigation and labeling (e.g., new sections like 'How to Read a Study Record' and 'How to Join a Study', as well as heading formatting and revision notes), which affect how the page is navigated but do not alter the core study data.SummaryDifference0.4%

- Check27 days agoChange Detected- Revision updated from v3.5.4 to v3.5.5, indicating a small update to the page's metadata/formatting rather than to the study content.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now includes a new revision tag, v3.5.4, replacing the previous v3.5.3, signaling a minor update to the page's revision history. This change is administrative and does not alter the study details or outcomes.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page footer revision has been updated from v3.5.2 to v3.5.3, indicating a minor site software/version update rather than a change to the clinical study information.SummaryDifference0.1%

- Check77 days agoChange Detected- Revision updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.